Literature DB >> 240271

Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).

J U Ikonne, M C Rattazzi, R J Desnick.   

Abstract

Hex S, the major residual beta hexosaminidase activity present in tissues, fluids, and cultured skin fibroblasts of patients with type 0 GM2 gangliosidosis, was isolated and characterized biochemically and immunologically. when appropriate tissue homogenates were tested by electrophoresis on cellulose acetate gels, hex S as well as hex C, the corresponding minor beta hexosaminidase component found in normal visceral tissues, migrated with greater anodic mobilities than hex A. However, a small but reproducible electrophoretic difference was observed between partially purified hex S and hex C components. Hex S and hex C had slightly higher apparent molecular weights than those of hex A or hex G; no major differences were found between hex S and hex A in thermostability, pH optimum, or kinetic properties. Hex S, like hex C from placenta, reacted with an antiserum directed towards the unique antigenic determinants alpha of hex A, indicating that hex S, hex C, and hex A share a common antigenic determinant. No reactivity of hex S was detected with an antiserum directed toward the common antigenic determinant beta of hex A and hex B. These results suggest that further biochemical and immunologic characterization of hex S and elucidation of its relationships with hex A, hex B, and hex C may significantly contribute to the understanding of the molecular defects in the GM2 gangliosidoses.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240271      PMCID: PMC1762835     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Isolation and relationship of human hexosaminidases.

Authors:  J F Tallman; R O Brady; J M Quirk; M Villalba; A E Gal
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

2.  Studies on human beta-D-N-acetylhexosaminidases. I. Purification and properties.

Authors:  S K Srivastava; Y C Awasthi; A Yoshida; E Beutler
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

3.  Conversion of human hexosaminidase A to hexosaminidase "B" by crude Vibrio cholerae neuraminidase preparations: merthiolate is the active factor.

Authors:  P J Carmody; M C Rattazzi
Journal:  Biochim Biophys Acta       Date:  1974-11-05

4.  Separation and properties of human brain hexosaminidase C.

Authors:  I Braidman; M Carroll; N Dance; D Robinson
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

5.  Characterisation of human N-acetyl-beta-hexosaminidase C.

Authors:  I Braidman; M Carroll; N Dance; D Robinson; L Poenaru; A Weber; J C Dreyfus; B Overdijk; G J Hooghwinkel
Journal:  FEBS Lett       Date:  1974-05-01       Impact factor: 4.124

6.  On the molecular basis of Sandhoff's disease.

Authors:  H H Ropers; U Schwantes
Journal:  Humangenetik       Date:  1973

7.  Studies on human beta-D-N-acetylhexosaminidases. 3. Biochemical genetics of Tay-Sachs and Sandhoff's diseases.

Authors:  S K Srivastava; E Beutler
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

8.  Immunological properties of N-acetyl-beta-D-glucosaminidase of normal human liver and of GM2-gangliosidosis liver.

Authors:  M Carroll; D Robinson
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

9.  Immunochemical characterization of human beta-D-N-acetyl hexosaminidase from normal individuals and patients with Tay-Sachs disease. I. Antigenic differences between hexosaminidase A and hexosaminidase B.

Authors:  W R Bartholomew; M C Rattazzi
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

10.  A low-molecular-weight protein cross-reacting with human liver N-acetyl-beta-D-glucosaminidase.

Authors:  M Carroll; D Robinson
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

View more
  28 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

3.  The subunits of human hexosaminidase A.

Authors:  E Beutler; A Yoshida; W Kuhl; J E Lee
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

Review 4.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

Review 5.  Progress in investigations of sphingolipidoses.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

6.  Characterization of a variant of beta-hexosaminidase: "hexosaminidase Paris".

Authors:  J C Dreyfus; L Poenaru; M Vibert; N Ravise; J Boue
Journal:  Am J Hum Genet       Date:  1977-05       Impact factor: 11.025

7.  Studies on human N-acetyl-Beta-d-hexosaminidase C separated from neonatal brain.

Authors:  G T Besley; D M Broadhead
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

8.  Incidence and carrier frequency of Sandhoff disease in Saskatchewan determined using a novel substrate with detection by tandem mass spectrometry and molecular genetic analysis.

Authors:  Braden Fitterer; Patricia Hall; Nick Antonishyn; Rajagopal Desikan; Michael Gelb; Denis Lehotay
Journal:  Mol Genet Metab       Date:  2014-01-13       Impact factor: 4.797

9.  Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.

Authors:  M C Rattazzi; J A Brown; R G Davidson; T B Shows
Journal:  Am J Hum Genet       Date:  1976-03       Impact factor: 11.025

10.  Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).

Authors:  E Beutler; W Kuhl; D Comings
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.